Imminent launch of grant-funded clinical trial in graft-versus-host disease (GVHD)Advancing clinical program in severe pulmonary inflammatory ...

CancerBuddy connects users through shared diagnoses and experiences, offering community when hospital walls feel especially ...

Orca Bio spent the past few years building out a 100,000-square-foot facility in Metro Air Park near the Sacramento International Airport.

UCLA researchers have made strides in developing a stem cell gene therapy for alpha thalassemia major, a severe, inherited ...

Led by former founders of a biotech AstraZeneca acquired in 2023, AllRock Bio is starting out with a drug licensed from ...

The first national, multi-center study to evaluate the full donor search process using a score-based strategy, 1 researchers tested whether the approach could help transplant centers avoid lengthy, ...

Mesoblast Chief Executive Silviu Itescu reiterated the strong first quarter launch of Ryoncil ® and product sales in the treatment of children with steroid-refractory acute graft versus host disease ...

Researchers have created a novel immunotherapy for metastatic kidney cancer that could provide a new treatment option for ...

Incyte secures FDA nod for Opzeluras pediatric use in atopic dermatitis, marking its third U.S. approval and boosting sales ...

The U.S. Department of Energy's National Nuclear Security Administration has removed Cesium-137 Irradiators from medical ...

During a live event, Michael R. Bishop, MD, discussed a case of steroid-refractory GVHD and the efficacy and safety outcomes ...

Seven-year-old Avukile from KwaZulu-Natal triumphed over acute lymphoblastic leukaemia, reaching a significant milestone ...